UNH financials
UnitedHealth Group Incorporated · end-of-day data as of Oct 16, 2026
UnitedHealth Group Incorporated
$401.43-4.0%
Buy · 26 analystsPT $460.17 +14.6%
UNH reported revenue of $113B for the quarter ended Sep 30, 2026 (Q3 FY2026), down 0.4% from a year earlier. It posted diluted EPS of $4.56, free cash flow of $4.26B and a net margin of 3.6%.
Valuation
- P/E22.9x
- P/E vs own-1.6%
- P/E vs sector-18.6%
- FCF yield+6.3%
- Market cap$360B
Quarterly results
Q3 FY2026: Revenue -0.4% year over year, free cash flow 3.8% of revenue, operating margin 5.8%.
RevenueFree cash flow
| Q3 FY2026 | Sep 30, 2026 | $113B | 4.56 | $4.26B | 100.0% | 5.8% | 3.6% |
| Q2 FY2026 | Jun 30, 2026 | $112B | 6.05 | $10.25B | 32.7% | 7.1% | 4.9% |
| Q1 FY2026 | Mar 31, 2026 | $112B | 6.90 | $8.15B | 22.7% | 8.0% | 5.6% |
| Q4 FY2025 | Dec 31, 2025 | $113B | 0.01 | $160M | 16.3% | 0.3% | 0.0% |
| Q3 FY2025 | Sep 30, 2025 | $113B | 2.59 | $5.05B | 18.2% | 3.8% | 2.1% |
| Q2 FY2025 | Jun 30, 2025 | $112B | 3.74 | $6.3B | 17.9% | 4.6% | 3.1% |
| Q1 FY2025 | Mar 31, 2025 | $110B | 6.85 | $4.56B | 21.7% | 8.3% | 5.7% |
| Q4 FY2024 | Dec 31, 2024 | $101B | 5.98 | $1.46B | 21.1% | 7.7% | 5.5% |
| Q3 FY2024 | Sep 30, 2024 | $101B | 6.51 | $12.95B | 22.8% | 8.6% | 6.0% |
| Q2 FY2024 | Jun 30, 2024 | $98.86B | 4.54 | $5.89B | 22.3% | 8.0% | 4.3% |
| Q1 FY2024 | Mar 31, 2024 | $99.8B | -1.53 | $401M | 23.1% | 7.9% | -1.4% |
| Q4 FY2023 | Dec 31, 2023 | $94.43B | 5.83 | -$6.15B | 23.3% | 8.1% | 5.8% |